Furthermore, as the activation of the antioxidant transcription factor NRF2 can revert ferroptosis [9,10,11], and NRF2 appears promising as a neuroprotective factor in epileptogenesis and chronic epilepsy animal models [15,18,19,20,21,22], we evaluated the gene expression of NRF2 in the blood of children with epilepsy. Here, NFE2L2 is linked to epilepsy.